Literature DB >> 20015693

Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3.

Angela Nagel1, Angelika Lang, Dorothee Engel, Eva Podstawa, Nicolas Hunzelmann, Ornella de Pita, Luca Borradori, Wolfgang Uter, Michael Hertl.   

Abstract

Pemphigus vulgaris (PV) is a severe autoimmune bullous skin disease and is primarily associated with IgG against desmoglein 3 (dsg3), a desmosomal adhesion protein. In light of the recent association of autoreactive T helper (Th) 2 cells with active PV, the present study sought to relate the occurrence of Th2-regulated dsg3-specific autoantibody subtypes, i.e. IgE and IgG4, in 93 well-characterized PV patients. Patients with acute onset PV (n=37) showed the highest concentrations of serum IgE and IgG4 autoantibodies, which were significantly lower in PV patients in remission (n=14). Furthermore, there was a strong correlation between dsg3-reactive IgE and IgG4 in acute onset, but not in chronic active (n=42) or remittent patients. Additionally, intercellular IgE deposits were detected in the epidermis of acute onset PV. Thus, dsg3-specific IgE and IgG4 autoantibodies are related to acute onset disease which provides additional support to the concept that PV is a Th2-driven autoimmune disorder. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015693     DOI: 10.1016/j.clim.2009.11.006

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  22 in total

Review 1.  Non-infectious environmental antigens as a trigger for the initiation of an autoimmune skin disease.

Authors:  Ye Qian; Donna A Culton; Joseph S Jeong; Nicole Trupiano; Jesus G Valenzuela; Luis A Diaz
Journal:  Autoimmun Rev       Date:  2016-07-08       Impact factor: 9.754

Review 2.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 3.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

4.  IgE, IgM, and IgG4 anti-desmoglein 1 autoantibody profile in endemic pemphigus foliaceus (fogo selvagem).

Authors:  Ye Qian; Phillip Prisayanh; Eugenio Andraca; Bahjat F Qaqish; Valeria Aoki; Gunter Hans-Filhio; Evandro A Rivitti; Luis A Diaz
Journal:  J Invest Dermatol       Date:  2010-12-30       Impact factor: 8.551

5.  Walnut antigens can trigger autoantibody development in patients with pemphigus vulgaris through a "hit-and-run" mechanism.

Authors:  Lan Lin; Timothy P Moran; Bin Peng; Jinsheng Yang; Donna A Culton; Huilian Che; Songsong Jiang; Zhi Liu; Songmei Geng; Yuzhu Zhang; Luis A Diaz; Ye Qian
Journal:  J Allergy Clin Immunol       Date:  2019-05-06       Impact factor: 10.793

6.  Targeted immunotherapy with rituximab leads to a transient alteration of the IgG autoantibody profile in pemphigus vulgaris.

Authors:  Ralf Müller; Nicolas Hunzelmann; Vera Baur; Guido Siebenhaar; Elke Wenzel; Rüdiger Eming; Andrea Niedermeier; Philippe Musette; Pascal Joly; Michael Hertl
Journal:  Dermatol Res Pract       Date:  2010-06-30

7.  CTLA4Fcε, a novel soluble fusion protein that binds B7 molecules and the IgE receptors, and reduces human in vitro soluble CD23 production and lymphocyte proliferation.

Authors:  Daniel Perez-Witzke; María Auxiliadora Miranda-García; Nuris Suárez; Raquel Becerra; Kharelys Duque; Verónica Porras; Jaheli Fuenmayor; Ramon Fernando Montano
Journal:  Immunology       Date:  2016-03-08       Impact factor: 7.397

8.  Uric Acid: a new antioxidant in patients with pemphigus vulgaris.

Authors:  Maryam Yousefi; Hoda Rahimi; Behrooz Barikbin; Parviz Toossi; Sara Lotfi; Mehdi Hedayati; Shima Younespour
Journal:  Indian J Dermatol       Date:  2011-05       Impact factor: 1.494

Review 9.  Skin barrier disruption: a requirement for allergen sensitization?

Authors:  Anna De Benedetto; Akiharu Kubo; Lisa A Beck
Journal:  J Invest Dermatol       Date:  2012-01-05       Impact factor: 8.551

Review 10.  Pemphigus autoimmunity: hypotheses and realities.

Authors:  Sergei A Grando
Journal:  Autoimmunity       Date:  2011-09-23       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.